Incyte Corp at Goldman Sachs CEOs Unscripted Conference Transcript
Great. Good morning, everyone. Thanks so much for joining us. We're really pleased to have Herve Hoppenot, Chairman, President and CEO of Incyte with us. And in the audience, we do have Christiana Stamoulis, CFO, as well. So thank you both.
Questions & Answers
Herve, just to start here, a high-level outlook. Product diversification for Incyte has been a focus. And as you stand today with Jakafi, Pemazyre, Monjuvi, Opzelura, and the current pipeline, what is your outlook for the business at this point and growth in the medium and long term?
Salveen, thank you for inviting me. It's a pleasure to start the year here and speak about Incyte. So Incyte is obviously about innovation and growth. I mean that's really what the agenda is for us and has been for the past 5 years. And if you look back at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
